Trials / Unknown
UnknownNCT04983563
Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units
Assessment of Actigraphy in the Management of Neonatal Opioid Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of this study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome of hospitalized newborn in intensive care units
Detailed description
Hospitalized newborn in intensive care units can receive opioids to manage pain or sedation. Neonatal opioid abstinence syndrome can occur when newborn receive opioid treatment for a long time. Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal abstinence syndrome but they are subjective. The majority of items in these scores are motor skills items. Actigraphy allows to measure objectively the newborn motricity. This study will analyse the correlation between actigraphy and Lipsitz scoring system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actigraphy, eTact | Actigraphy will be realized twice a day during 30 minutes and Lipsitz scoring system will be realized at the same moment to analyze the correlation between Lipsitz scoring system and actigraphy. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2021-07-30
- Last updated
- 2021-07-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04983563. Inclusion in this directory is not an endorsement.